Hormone levels are associated with clinical markers and cytokine levels in human localized cutaneous leishmaniasis

Brain, Behavior, and Immunity

Volumn 25, Issue 3, 2011, Pages 548-554

  Baccan, Gyselle Chrystina ^a,b   Oliveira, Fabiano ^b,d   Sousa, Adenilma Duranes ^a   Cerqueira, Natali Alexandrino ^b   Costa, Jackson Mauricio Lopes ^b   Barral Netto, Manoel ^a,b,c   Barral, Aldina ^a,b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Instituto de Investigação em Imunologia   (Brazil)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Clinical markers; Cytokines; Hormones; Localized cutaneous leishmaniasis; Neuroendocrine regulation

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; ESTRADIOL; HORMONE; HYDROCORTISONE; INTERLEUKIN 10; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; NEUROENDOCRINE SYSTEM; PARASITE CLEARANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; SKIN LEISHMANIASIS; TESTOSTERONE BLOOD LEVEL; TH1 CELL;

ADULT; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADAL STEROID HORMONES; HUMANS; HYDROCORTISONE; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PROLACTIN;

EID: 79551689534     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.12.009     Document Type: Article

References (53)

1. Ajdary S., Alimohammadian M.H., Eslami M.B., Kemp K., Kharazmi A. Comparison of the immune profile of nonhealing cutaneous leishmaniasis patients with those with active lesions and those who have recovered from infection. Infect Immun. 2000, 68:1760-1764.
2. Alexander J. Sex differences and cross-immunity in DBA/2 mice infected with L. Mexicana and L. major. Parasitology 1988, 96:297-302.
3. Alexander J., Bryson K. T helper (h)1/Th2 and Leishmania: paradox rather than paradigm. Immunol. Lett. 2005, 99(1):17-23.
4. Ansar A.S., Penhale W.J., Talal N. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am. J. Pathol. 1985, 121:531-551.
5. Ashwell J.D., Lu F.W., Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 2000, 18:309-345.
6. Berkenbosch F., Van Oers J., Del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238(4826):524-526.
7. Besedovsky H., Del Rey A., Sorkin E., Dinarello C.A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986, 233(4764):652-654.
8. Bhasin S., Singh A.B., Javanbakht M. Neuroendocrine abnormalities associated with HIV infection. Endocrinol. Metab. Clin. North Am. 2001, 30(3):749-764.
9. Boom W.H., Liebster L., Abbas A.K., Titus R.G. Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution. Infect. Immun. 1990, 58:3863-3870.
10. Brand J.M., Frohn C., Cziupka K., Brockmann C., Kirchner H., Luhm J. Prolactin triggers pro-inflammatory immune responses in peripheral immune cells. Eur. Cytokine Netw. 2004, 15(2):99-104.
11. Butterworth M., McClellan B., Allansmith M. Influence of sex in immunoglobulin levels. Nature 1967, 214:1224-1225.
12. Carvalho E.M., Johnson W.D., Barreto E., Marsden P.D., Costa J.L., Reed S., Rocha H. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 1985, 135(6):4144-4148.
13. Corrêa-de-Santana E., Paez-Pereda M., Theodoropoulou M., Nihei K.O., Gruebler Y., Bozza M., Arzt E., Villa-Verde D.M., Renner U., Stalla J., Stalla G.K., Savino W. Hypothalamus-pituitary-adrenal axis during Trypanosoma cruzi acute infection in mice. J. Neuroimmunol. 2006, 173(1-2):12-22.
14. Cutolo M., Sulli A., Capellino S., Villaggio B., Montagna P., Seriolo B., Straub R.H. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004, 13(9):635-638.
15. De Moura T.R., Novais F.O., Oliveira F., Clarencio J., Noronha A., Barral A., Brodskyn C., de Oliveira C.I. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect. Immun. 2005, 73:5827-5834.
16. De Oliveira C.I., Báfica A., Oliveira F., Favali C.B., Correa T., Freitas L.A., Nascimento E., Costa J.M., Barral A. Clinical utility of polymerase chain reaction-based detection of Leishmania in the diagnosis of American cutaneous leishmaniasis. Clin. Infect. Dis. 2003, 37(11):49-53.
17. Del Rey A., Mahuad C.V., Bozza V.V., Bogue C., Farroni M.A., Bay M.L., Bottasso O.A., Besedovsky H.O. Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav. Immun. 2007, 21:171-179.
18. Dimitrov S., Lange T., Fehm H.L., Born J. A regulatory role of prolactin, growth hormone, and corticosteroids for human T-cell production of cytokines. Brain Behav. Immun. 2004, 18(4):368-374.
19. Ehrchen J., Sindrilaru A., Grabbe S., Schönlau F., Schlesiger C., Sorg C., Scharffetter-Kochanek K., Sunderkötter C. Senescent BALB/c mice are able to develop resistance to Leishmania major infection. Infect. Immun. 2004, 72(9):5109-5114.
20. Gallindo-Sevilla N., Soto N., Mancilla J., Cerbulo A., Zambrano E., Chavira R., Huerto J. Low serum levels of dehydroepiandrosterone and cortisol in human diffuse cutaneous leishmaniasis by Leishmania mexicana. Am. J. Trop. Med. Hyg. 2007, 76(3):566-572.
21. Grimaldi G., Tesh R.B., McMahon-Pratt D. A review of the geographic distribution and epidemiology of leishmaniasis in the New World. Am. J. Trop. Med. Hyg. 1989, 41(6):687-725.
22. Hazeldine J., Arlt W., Lord J.M. Dehydroepiandrosterone as a regulator of immune cell function. J Steroid Biochem. Mol. Biol. 2010, 120:127-136.
23. Holsboer F., Stalla G.K., Von Bardeleben U., Hammann K., Müller H., Müller O.A. Acute adrenocortical stimulation by recombinant gamma interferon in human controls. Life Sci. 1988, 42(1):1-5.
24. Janele D., Lang T., Capellino S., Cutolo M., Da Silva J.A., Straub R.H. Effects of testosterone, 17beta-estradiol, and downstream estrogens on cytokine secretion from human leukocytes in the presence and absence of cortisol. Ann. NY Acad. Sci. 2006, 1069:168-182.
25. Kanda N., Tamaki K. Estrogen enhances immunoglobulin production by human PBMCs. J. Allergy Clin. Immunol. 1999, 103(2 Pt 1):282-288.
26. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 2000, 191:1063-1067.
27. Klein S.L. Hormonal and immunological mechanisms mediating sex differences in parasite infection. Parasite Immunol. 2004, 26(6-7):247-264.
28. Kurtis J.D., Mtalib R., Onyango F.K., Duffy P.E. Human resistance to Plasmodium falciparum increases during puberty and is predicted by dehydroepiandrosterone sulfate levels. Infect. Immun. 2001, 69(1):123-128.
29. Leal A.M., Magalhães P.K., Souza C.S., Foss N.T. Pituitary-gonadal hormones and interleukin patterns in leprosy. Trop. Med. Int. Health 2006, 11(9):1416-1421.
30. Leal A.M., Magalhães P.K., Souza C.S., Foss N.T. Adrenocortical hormones and interleukin patterns in leprosy. Parasite Immunol. 2003, 25(8-9):457-461.
31. Libonati R.M.F., Mendonça B.B., Maués J.A., Quaresma J.A.S., Souza J.M. Some aspects of the behavior of the hypothalamus-pituitary-adrenal axis in patients with uncomplicated Plasmodium falciparum malaria: cortisol and dehydroepiandrosterone levels. Acta Trop. 2006, 98:270-276.
32. Mavoungou D., Poaty-Mavoungou V., Ongali B., Akoume M.Y., Maka G., Mavoungou E. Hypothalamic-pituitary gonadal axis and immune response imbalance during chronic filarial infections. Trop. Med. Int. Health 2005, 10(2):1180-1186.
33. Mock B.A., Nacy C.A. Hormonal modulation of sex differences in resistance to Leishmania major systemic infections. Infect. Immun. 1988, 56:3316-3319.
34. Motta A.C., Arruda D., Souza C.S., Foss N.T. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Int. J. Dermatol. 2003, 42(9):703-706.
35. Naitoh Y., Fukata J., Tominaga T., Nakai Y., Tamai S., Mori K., Imura H. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats. Biochem. Biophys. Res. Commun. 1988, 155(3):1459-1463.
36. Olsen N.J., Kovacs W.J. Gonadal steroids and immunity. Endocr. Rev. 1996, 17(4):369-384.
37. Pinto R.A., Arredondo S.M., Bono M.R., Gaggero A.A., Diaz P. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial vírus infection is associated with increased endogenous plasma cortisol. Pediatrics 2007, 117:878-881.
38. Pittalis S., Nicastri E., Spinazzola F., Ghirga P., De Marco M., Paglia M.G., Narciso P. Leishmania infantum leishmaniasis in corticosteroid-treated patients. BMC Infect. Dis. 2006, 6:177-180.
39. Ramírez F., Fowell D.J., Puklavec M., Simmonds S., Mason D. Glucocorticoids promote a TH2 cytokine response by CD4+ T cells in vitro. J. Immunol. 1996, 156(7):2406-2412.
40. Reincke M., Arlt W., Heppner C., Petzke F., Chrousos G.P., Allolio B. Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines. Ann. NY Acad. Sci. 1998, 1:809-821.
41. Rousseau D., Suffia I., Ferrua B., Philip P., Le Fichoux Y., Kubar J.L. Prolonged administration of dexamethasone induces limited reactivation of visceral leishmaniasis in chronically infected BALB/c mice. Eur. Cytokine Netw. 1998, 9(4):655-661.
42. Ruiz M.R., Quinines A.G., Diaz N.L., Tapia F.J. Acute immobilization stress induces clinical and neuroimmunological alterations in experimental murine cutaneous leishmaniasis. Brit. J. Dermat. 2003, 149:731-738.
43. Sharp B.M., Matta S.G., Peterson P.K., Newton R., Chao C., Mcallen K. Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta. Endocrinology 1989, 124(6):3131-3133.
44. Spencer N.F., Norton S.D., Harrison L.L., Li G.Z., Daynes R.A. Dysregulation of IL-10 production with aging: possible linkage to the age-associated decline in DHEA and its sulfated derivative. Exp. Gerontol. 1996, 31(3):393-408.
45. Straub R.H., Konecna L., Hrach S., Rothe G., Kreutz M., Schölmerich J., Falk W., Lang B. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J. Clin. Endocrinol. Metab. 1998, 83(6):2012-2017.
46. Straub R.H. The complex role of estrogens in inflammation. Endocr. Rev. 2007, 28(5):521-574.
47. Suzuki T., Suzuki N., Daynes R.A., Engleman E.G. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin. Immunol. Immunopathol. 1991, 61(2 Pt 1):202-211.
48. Travi B.L., Osorio Y., Melby P.C., Chandrasekar B., Arteaga L., Saravia N.G. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infect. Immun. 2002, 70(5):2288-2296.
49. Tuon F.F., Sabbaga Amato V., Floeter-Winter L.M., de Andrade Zampieri R., Amato Neto V., Siqueira França F.O., Shikanai-Yasuda M.A. Cutaneous leishmaniasis reactivation 2 years after treatment caused by systemic corticosteroids - first report. Int. J. Dermatol. 2007, 46(6):628-630.
50. Walton P.E., Cronin M.J. Tumor necrosis factor-alpha and interferon-gamma reduce prolactin release in vitro. Am. J. Physiol. 1990, 259:672-676.
51. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 2002, 20:125-163.
52. World Health Organization Leishmaniasis: burden of disease 2007 2007, World Health Organization, Geneva.
53. Zhang H., Zhao J., Wang P., Qiao Z. Effect of testosterone on Leishmania donovani infection of macrophages. Parasitol. Res. 2001, 87(8):674-676.